Temel JS - Search Results

1

A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.

Heist RS, Fidias P, Huberman M, Ardman B, Sequist LV, Temel JS, Lynch TJ. Heist RS, et al. Among authors: temel js. J Thorac Oncol. 2008 Oct;3(10):1153-8. doi: 10.1097/JTO.0b013e318187273f. J Thorac Oncol. 2008. PMID: 18827612 Free article. Clinical Trial.

2

Can weight loss at presentation predict patient outcome in lung cancer?

Temel J. Temel J. Nat Clin Pract Oncol. 2004 Dec;1(2):68-9. doi: 10.1038/ncponc0033. Nat Clin Pract Oncol. 2004. PMID: 16264819 No abstract available.

3

Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer.

Temel JS, Pirl WF, Lynch TJ. Temel JS, et al. Clin Lung Cancer. 2006 Jan;7(4):241-9. doi: 10.3816/CLC.2006.n.001. Clin Lung Cancer. 2006. PMID: 16512977 Review.

4

Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.

Jackman DM, Yeap BY, Lindeman NI, Fidias P, Rabin MS, Temel J, Skarin AT, Meyerson M, Holmes AJ, Borras AM, Freidlin B, Ostler PA, Lucca J, Lynch TJ, Johnson BE, Jänne PA. Jackman DM, et al. J Clin Oncol. 2007 Mar 1;25(7):760-6. doi: 10.1200/JCO.2006.07.5754. Epub 2007 Jan 16. J Clin Oncol. 2007. PMID: 17228019 Clinical Trial.

5

Complexities of quality of life analysis in non-small cell lung cancer.

Temel J. Temel J. J Support Oncol. 2007 Jan;5(1):30-1. J Support Oncol. 2007. PMID: 17265784 Review. No abstract available.

6

Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?

Shi AA, Digumarthy SR, Temel JS, Halpern EF, Kuester LB, Aquino SL. Shi AA, et al. Among authors: temel js. J Thorac Oncol. 2006 Mar;1(3):205-10. doi: 10.1016/s1556-0864(15)31569-0. J Thorac Oncol. 2006. PMID: 17409858 Free article.

7

Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic.

Temel JS, Pirl WF, Recklitis CJ, Cashavelly B, Lynch TJ. Temel JS, et al. J Thorac Oncol. 2006 Jun;1(5):454-9. J Thorac Oncol. 2006. PMID: 17409899 Free article.

8

Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.

Temel JS, Jackson VA, Billings JA, Dahlin C, Block SD, Buss MK, Ostler P, Fidias P, Muzikansky A, Greer JA, Pirl WF, Lynch TJ. Temel JS, et al. J Clin Oncol. 2007 Jun 10;25(17):2377-82. doi: 10.1200/JCO.2006.09.2627. J Clin Oncol. 2007. PMID: 17557950 Clinical Trial.

9

A phase II study of gefitinib in patients with advanced thyroid cancer.

Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ. Pennell NA, et al. Among authors: temel js. Thyroid. 2008 Mar;18(3):317-23. doi: 10.1089/thy.2007.0120. Thyroid. 2008. PMID: 17985985 Clinical Trial.

10

A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.

Bradbury PA, Heist RS, Kulke MH, Zhou W, Marshall AL, Miller DP, Su L, Park S, Temel J, Fidias P, Sequist L, Lynch TJ, Wain JC, Shepherd FA, Christiani DC, Liu G. Bradbury PA, et al. Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):204-11. doi: 10.1158/1055-9965.EPI-07-0470. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18199725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters